Stay updated on Nivolumab Plus Ipilimumab in Melanoma Clinical Trial

Sign up to get notified when there's something new on the Nivolumab Plus Ipilimumab in Melanoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Nivolumab Plus Ipilimumab in Melanoma Clinical Trial page

  1. Check
    3 days ago
    Change Detected
    Summary
    Padova, Italy, 35128 added to the locations and Padua, Italy, 35128 removed, updating the site listing to the Italian spelling.
    Difference
    0.1%
    Check dated 2026-04-09T08:05:46.000Z thumbnail image
  2. Check
    10 days ago
    Change Detected
    Summary
    Added Melanoma as a topic on the page. Related topics now include MedlinePlus Genetics.
    Difference
    0.1%
    Check dated 2026-04-02T00:11:07.000Z thumbnail image
  3. Check
    17 days ago
    Change Detected
    Summary
    Naples, Italy 80131 was added as a study location and Napoli, Italy 80131 was removed, with a revision update to v3.5.0.
    Difference
    0.1%
    Check dated 2026-03-25T20:09:16.000Z thumbnail image
  4. Check
    25 days ago
    Change Detected
    Summary
    No substantive content changes detected; the additions and deletions sections are empty, and the study details appear unchanged.
    Difference
    0.0%
    Check dated 2026-03-18T12:22:18.000Z thumbnail image
  5. Check
    31 days ago
    Change Detected
    Summary
    Added related topics: Melanoma and MedlinePlus Genetics; updated the page revision from v3.4.2 to v3.4.3.
    Difference
    0.1%
    Check dated 2026-03-11T17:58:46.000Z thumbnail image
  6. Check
    60 days ago
    Change Detected
    Summary
    Added Revision: v3.4.2; removed the funding-status notice, older Revision: v3.4.1 reference, and melanoma-related topic tags.
    Difference
    0.3%
    Check dated 2026-02-11T06:18:06.000Z thumbnail image

Stay in the know with updates to Nivolumab Plus Ipilimumab in Melanoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Nivolumab Plus Ipilimumab in Melanoma Clinical Trial page.